Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Investigating the metabolic benefits of intermittent fasting-induced ketogenesis in a non-alcoholic fatty liver disease model
FY 2019-20
Summary
Investigating the metabolic benefits of intermittent fasting-induced ketogenesis in a non-alcoholic fatty liver disease model
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disorder in the world. The disease is characterized by the build-up of excess fat in the liver, progressing to liver tissue inflammation and scarring, as well as in extreme cases liver cancer. Currently there are no therapeutic interventions for the direct treatment of NAFLD, rather patients are often advised with lifestyle adjustments (i.e. exercise and diet-restriction), to manage the complications of the disease (i.e. obesity and insulin resistance).
Intermittent fasting has become a popular dietary intervention that has shown metabolic benefits against several diseases in both human and animal models. Fasting promotes the upregulation of ketogenesis for the production of ketone bodies. Besides providing an additional fuel source to non-liver tissues, ketone bodies have also been implied in the protection of cardiovascular, nervous system, and liver diseases, through their roles in mediating anti-inflammatory and antioxidant responses.
However, the mechanism by which intermittent fasting confers its metabolic benefits in a disease model, such as NAFLD, has not yet been explored. Thus, I hypothesize that intermittent fasting-induced activation of ketogenesis will have therapeutic applications against NAFLD. To test this hypothesis, I will utilize both cell (in vitro) and mouse (in vivo) studies mimicking ketogenesis insufficiency and ketogenesis upregulation, to better understand the underlying mechanism of ketone body-mediated protection and treatment of NAFLD. This information will be crucial in developing successful NAFLD-directed therapeutics.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
430764
Name
Asif Shaza
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the metabolic benefits of intermittent fasting-induced ketogenesis in a non-alcoholic fatty liver disease model
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autophagy; Beta-Hydroxybutyrate (Bhb),; Hepatic Steatosis; Hepatology; Hmgcs2; Intermittent Fasting; Ketogenesis; Ketone Bodies; Metabolism; Non-Alcoholic Fatty Liver Disease (Nafld)
Abstract
Investigating the metabolic benefits of intermittent fasting-induced ketogenesis in a non-alcoholic fatty liver disease model
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disorder in the world. The disease is characterized by the build-up of excess fat in the liver, progressing to liver tissue inflammation and scarring, as well as in extreme cases liver cancer. Currently there are no therapeutic interventions for the direct treatment of NAFLD, rather patients are often advised with lifestyle adjustments (i.e. exercise and diet-restriction), to manage the complications of the disease (i.e. obesity and insulin resistance).
Intermittent fasting has become a popular dietary intervention that has shown metabolic benefits against several diseases in both human and animal models. Fasting promotes the upregulation of ketogenesis for the production of ketone bodies. Besides providing an additional fuel source to non-liver tissues, ketone bodies have also been implied in the protection of cardiovascular, nervous system, and liver diseases, through their roles in mediating anti-inflammatory and antioxidant responses.
However, the mechanism by which intermittent fasting confers its metabolic benefits in a disease model, such as NAFLD, has not yet been explored. Thus, I hypothesize that intermittent fasting-induced activation of ketogenesis will have therapeutic applications against NAFLD. To test this hypothesis, I will utilize both cell (in vitro) and mouse (in vivo) studies mimicking ketogenesis insufficiency and ketogenesis upregulation, to better understand the underlying mechanism of ketone body-mediated protection and treatment of NAFLD. This information will be crucial in developing successful NAFLD-directed therapeutics.
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Asif, Shaza
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~